A Gatineau-based medical marijuana firm with a self-declared goal of becoming the “Coca-Cola of cannabis” says it will start trading on the TSX Venture Exchange Tuesday.
The Hydropothecary Corp., which is licensed by Health Canada to produce and distribute medical marijuana, will trade under the symbol “THCX” following a reverse takeover.
“Today, we are making history,” said Sebastien St-Louis, Hydropothecary’s co-founder and CEO. “Our company has proven that … innovation, uncompromising quality and concierge service are a winning combination.”
OBJ360 (Sponsored)
![Queensway Carleton Hospital Lumiere fundraiser](https://assets.obj.ca/2024/06/Lumiere_20240628_135436_0000-300x169.jpg)
Get ready to ROCK! The Lumière Gala returns to the Brookstreet this September
Brookstreet has always been a rock star in the world of hospitality. Now, the hotel is truly embracing the rock and roll vibe with this year’s themed gala in support
![A happy family with young children](https://assets.obj.ca/2024/07/Deloitte-20240705_102801_0000-300x169.jpg)
Smooth moves in the modern service era
A veteran of the Royal Canadian Navy, Darren Hawco’s life in the Canadian Armed Forces brought him from coast to coast, with command postings at sea, to top level positions
Company officials say Hydropothecary has a market capitalization value of $53 million with $21.4 million in cash on hand.
Hydropothecary says it’s Quebec’s first and only licensed producer of medical marijuana.
Last fall, it opened a new 36,000-square-foot growing facility that brought it to 42,000 square feet of space, allowing it to boost production to 3,600 kilograms a year from 600.
“We continue to sell basically everything we’re growing, so we’re happy about that,” chief operating officer Adam Miron said at the time.
The company was also looking to ramp up hiring by adding some 40 individuals to its existing payroll of 51 employees.
After opening the day at $1.82 per share, Hydropothecary stocks dropped 15 per cent to end at $1.55.